6-31972492-T-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_004197.2(STK19):āc.81T>Gā(p.Asp27Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000999 in 1,612,168 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_004197.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
STK19 | NM_004197.2 | c.81T>G | p.Asp27Glu | missense_variant | 1/7 | ENST00000685781.1 | NP_004188.2 | |
STK19 | NM_032454.1 | c.411T>G | p.Asp137Glu | missense_variant | 2/8 | NP_115830.1 | ||
STK19 | NR_026717.1 | n.724T>G | non_coding_transcript_exon_variant | 2/8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
STK19 | ENST00000685781.1 | c.81T>G | p.Asp27Glu | missense_variant | 1/7 | NM_004197.2 | ENSP00000509445.1 |
Frequencies
GnomAD3 genomes AF: 0.0000986 AC: 15AN: 152160Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000930 AC: 23AN: 247196Hom.: 0 AF XY: 0.0000965 AC XY: 13AN XY: 134696
GnomAD4 exome AF: 0.000100 AC: 146AN: 1460008Hom.: 0 Cov.: 31 AF XY: 0.000106 AC XY: 77AN XY: 726196
GnomAD4 genome AF: 0.0000986 AC: 15AN: 152160Hom.: 0 Cov.: 32 AF XY: 0.0000807 AC XY: 6AN XY: 74316
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 17, 2024 | The c.411T>G (p.D137E) alteration is located in exon 2 (coding exon 2) of the STK19 gene. This alteration results from a T to G substitution at nucleotide position 411, causing the aspartic acid (D) at amino acid position 137 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at